There were no items found based on the criteria entered.5 MIN WatchAugust 2022 It’s time to rethink what the word healthcare means
Supporting companies with the potential to transform the field of healthcare and generate attractive returns.January 2022 Health Innovation: impact and ESG.
Why the forthcoming Health Innovation Impact Strategy should focus minds.November 2021 The Biological Revolution.
The use of information science to unlock biology is revolutionising our health and wellbeing.October 2021 A shot in the arm.
Moderna’s mRNA vaccines are all set to become the cornerstone of an efficient health system.September 2021 Health Innovation Strategy turns to AI.
Creating a tool to help spot revolutionary healthcare companies.April 2021 A Dose of Innovation.
We are at the dawn of a golden age of medicine. We will soon have the ability to treat and cure diseases that have long been untreatable and incurable.April 2021 Injecting Optimism Into Healthcare’s Future.
Could the messenger RNA vaccines deployed against Covid, help fight cancer and other diseases? After a year of crisis, Julia Angeles, co-manager of Baillie Gifford’s Health Innovation Fund, looks at the positive signs.15 MIN ListenApril 2021 Episode 19 - Breaking the Biotech Model
Could the messenger RNA vaccines deployed against Covid, help fight cancer and other diseases? After a year of crisis, Julia Angeles, co-manager of Baillie Gifford’s Health Innovation Fund, looks at the positive signs.58 MIN WatchFebruary 2021 How the Pandemic is Revealing the Future of Healthcare.
Product specialist Jack Torrance talks to Julia Angeles and Marina Record, investment managers of the Health Innovation Strategy. The team discuss the journey they embarked upon to launch the strategy, the way in which 2020 has accelerated trends in the healthcare space, and what they think human health will look like in the future.WatchSeptember 2020 Data, AI & Ethics.
Julia Angeles, investment manager on the Health Innovation Team, speaks to Claire Bell, former newspaper journalist and inquisitive researcher for Baillie Gifford. Angeles and Bell discuss the hot topics of data, artificial intelligence and ethics.WatchJuly 2020 Health Innovation: It’s Time to Rethink What the Word ‘Healthcare’ Means.
We are in an era of great convergence. The Health Innovation strategy seeks to support this era of change by looking out for innovative and pioneering companies that have the potential to bring substantial improvements to human health and healthcare systems.February 2020 Healthcare Innovation.
We’re living longer, but are we living better? Baillie Gifford’s Health Innovation team is searching for companies whose cutting-edge science and innovative therapies are redefining healthcare. Put simply, healthcare has never looked as good for those seeking more from their investment.Third Quarter 2018 The Great Convergence of Medicine.
The future of medicine is likely to be fundamentally different from what we know today. Investment Manager, Rose Nguyen, discusses the technological advances that are likely to transform life science in the coming decades.Second Quarter 2018 Archived An End to Kidney Failure.
Many patients with kidney failure face an agonising wait for a donor or a life on dialysis. However, as Julia Angeles writes, new technologies may offer a brighter future.First Quarter 2017 Archived An End to Cancer?
Investment manager Julia Angeles strikes an optimistic note as she explores some of the recent developments in healthcare, which one day she hopes will bring an end to cancer.
You’ve viewed 15 of 15 results